Parsonage-Turner syndrome of the brachial plexus secondary to COVID-19 vaccine: A case report

Islam Mejri; Lenda Ben Hmida; Ines Bedoui; Tasnim Znegui; Maroua Kacem; Zied Moatemri; Hajer Derbali; Samia Jammeli; Nejiba Fekih Mrissa

doi:10.1002/ccr3.6483

Parsonage-Turner syndrome of the brachial plexus secondary to COVID-19 vaccine: A case report

Clin Case Rep. 2022 Oct 20;10(10):e6483. doi: 10.1002/ccr3.6483. eCollection 2022 Oct.

Authors

Islam Mejri^{1

2}, Lenda Ben Hmida^{1

2}, Ines Bedoui^{2

3}, Tasnim Znegui^{1

2}, Maroua Kacem^{1

2}, Zied Moatemri^{1

2}, Hajer Derbali^{2

3}, Samia Jammeli^{2

4}, Nejiba Fekih Mrissa^{2

5}

Affiliations

¹ Pneumology Department Military Hospital of Tunis Tunis Tunisia.
² Faculty of Medicine of Tunis University Tunis El Manar Tunis Tunisia.
³ Neurology Department Military Hospital of Tunis Tunis Tunisia.
⁴ Department of Rheumatology Rabta Hospital Tunis Tunisia.
⁵ Molecular Biology Unit (UR17DN06), Laboratory of Hematology Military Hospital of Tunis Tunis Tunisia.

Abstract

Parsonage-Turner syndrome (PTS) is a peripheral inflammatory neuropathy of unknown etiology. We present a rare case of a 50-year-old male patient with PTS post-COVID-19 BNT162b2 mRNA vaccine. Symptoms occurred 15 days after the second dose. He was treated with corticosteroids, analgesics, and physical rehabilitation with a partial recovery.

Keywords: COVID‐19; Parsonage–Turner syndrome; vaccine.

Publication types

Case Reports